Search clinical trials for: Single+hormone+artificial+pancreas

Total 385 results

Oregon Health and Science University
Xeris Pharmaceuticals

Completed

Three Way Crossover Closed Loop Study With Xeris Glucagon

Type1diabetes

United States
Oregon Health and Science University

Completed

Four Way Crossover Closed Loop With Exercise Detection

Type 1 Diabetes

United States
Institut de Recherches Cliniques de Montreal

Withdrawn

Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

Type 1 Diabetes Mellitus
Boston University Charles River Campus
Massachusetts General Hospital; National Institute of Diabetes and Digestive... and other collaborators

Completed

Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas (CL2)

Diabetes Mellitus

United States
Samuel Lunenfeld Research Institute, Mount Sinai...
McGill University Health Centre/Research Institute of the McGill University... and other collaborators

Completed

Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin (CLASS15)

Type1diabetes

Canada
Kochi University
University of Tokushima; Oita University

Unknown

Tight Glycemic Control by Artificial Pancreas (KMS)

Cardiovascular Diseases | Pancreatic Disease

Japan
Sansum Diabetes Research Institute
Harvard University

Completed

Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index

Type 1 Diabetes Mellitus

United States
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Recruiting

Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation (AP APPLE)

Type 1 Diabetes

United States
Huazhong University of Science and Technology

Completed

Clinical Application of an Open-source Artificial Pancreas System in Adult Inpatients With Diabetes

Diabetes Mellitus

China
Sansum Diabetes Research Institute
Harvard University

Completed

Safety and Feasibility Evaluation of the APS APP

Type 1 Diabetes Mellitus

United States
Nemours Children's Clinic
Jaeb Center for Health Research

Recruiting

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

Diabetes Mellitus, Type 1 | Child | Delivery of Health Care | Equipment and Supplies

United States
Rensselaer Polytechnic Institute
University of Colorado, Denver; Stanford University; Mount Sinai Hospital, New...

Completed

MMPPC Outpatient Clinical Protocol 2016 (MMPPC)

Type 1 Diabetes
Legacy Health System
Juvenile Diabetes Research Foundation

Completed

Artificial Pancreas Control System in an Outpatient Setting

Type 1 Diabetes Mellitus

United States
University of Virginia
DexCom, Inc.; Tandem Diabetes Care, Inc.

Withdrawn

Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney Transplantation

Type 1 Diabetes | End Stage Renal Disease (ESRD) | Insulin-requiring Type 2 Diabetes Mellitus
Insulet Corporation

Completed

Insulet Artificial Pancreas Early Feasibility Study

Type 1 Diabetes

United States
Sansum Diabetes Research Institute
Mayo Clinic; University of Padova; University of Virginia; University of California...

Completed

Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin (DP3)

Type 1 Diabetes Mellitus

United States
Rabin Medical Center

Withdrawn

Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes (MD-Logic- Cont)

Diabetes Type 1

Israel
University of Padova

Completed

Artificial Pancreas in Pediatric Patients (PEDarPAN) (PEDarPAN)

Type 1 Diabetes

Italy
University of Virginia
Juvenile Diabetes Research Foundation; University of California, Santa Barbara

Completed

Outpatient Control-to-Range: System and Monitoring Testing

Type 1 Diabetes Mellitus

United States
Legacy Health System
Juvenile Diabetes Research Foundation

Completed

Artificial Pancreas Control System in an Inpatient Setting

Type I Diabetes Mellitus

United States
Stanford University

Withdrawn

A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin Delivery

Type 1 Diabetes Mellitus

United States
Insulet Corporation

Completed

Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) (IDE2)

Type 1 Diabetes Mellitus

United States
Federico II University

Completed

OCT and OCT-A Deep Learning in Diabetic Patients Wiht Artificial Pancreas Device

Type 1 Diabetes Mellitus With Artificial Pancreas Device

Italy
Inreda Diabetic B.V.
Stichting Robopump; Rijnstate ziekenhuis; Kinder Diabetes Centrum Nijmegen

Completed

Portable Artificial Pancreas Applied for Youth and Adolescents (PAPAYA 1)

Diabetes Mellitus, Type 1

Netherlands
Massachusetts General Hospital
Boston University

Completed

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Type 1 Diabetes

United States
Massachusetts General Hospital

Terminated

Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise

Type 1 Diabetes Mellitus

United States
University of Virginia
University Hospital, Montpellier; University of Padova; University of California...

Completed

Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing

Type 1 Diabetes Mellitus

Italy
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Diabetes Mellitus, Type 1

United States, Netherlands, France, Italy
Rensselaer Polytechnic Institute
University of Colorado, Denver; University of California, San Diego; Stanford... and other collaborators

Unknown

Fault Detection, Zone MPC and DiAs System in T1D (ZoneMPC)

Type 1 Diabetes
Yale University
Harvard University

Completed

Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID) (HY-GRAID)

Type1 Diabetes

United States
Sansum Diabetes Research Institute
University of Virginia; University of California, Santa Barbara

Completed

Outpatient Control-to-Range: System and Monitoring Testing

Type 1 Diabetes Mellitus

United States
Oslo University Hospital

Completed

Cardiovascular Risk Factors After Single Pancreas Transplantation (Diamant)

Diabetes Type 1 | Endothelial Dysfunction

Norway
University of Virginia
University Hospital, Montpellier; University of Padova; University of California...

Completed

Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova (HomeCTR1_2)

Type 1 Diabetes Mellitus

Italy
Kochi University

Completed

Tight Glycemic Control by Artificial Pancreas

Pancreatic Neoplasm

Japan
Sansum Diabetes Research Institute
Mayo Clinic; Icahn School of Medicine at Mount Sinai; Harvard University

Completed

Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home

Type 1 Diabetes | Pregnancy

United States
University of Virginia
University Hospital, Montpellier; University of Padova; University of California...

Completed

Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier (HomeCTR1_1)

Type 1 Diabetes Mellitus

France
Sansum Diabetes Research Institute
Juvenile Diabetes Research Foundation; Schneider Children's Medical Center,...

Completed

Controlled Insulin Delivery: Combining Technology With Treatment

Diabetes Mellitus, Type 1

United States, Israel
McGill University

Completed

Efficacy of Closed-Loop Strategy With and Without a Learning Component in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp

Diabetes | Type 1 Diabetes Mellitus

Canada
Oregon Health and Science University

Completed

Three-way, Cross-over Closed-loop Exercise Study

Type 1 Diabetes

United States
Imperial College London

Completed

Clinical Assessment of a Closed-loop Insulin Delivery System

Type 1 Diabetes Mellitus

United Kingdom
Rabin Medical Center

Completed

Overnight MD-Logic

Type 1 Diabetes

Germany, Israel, Slovenia
Massachusetts General Hospital
Joslin Diabetes Center

Completed

Post Bariatric Closed Loop Glucagon Trial

Hypoglycemia

United States
McGill University Health Centre/Research Institute...
Juvenile Diabetes Research Foundation

Completed

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes (FCL)

Type 1 Diabetes

Canada
Academisch Medisch Centrum - Universiteit van Amsterdam...

Active, not recruiting

Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy (PANORAMA)

Pancreatic Neoplasms | Total Pancreatectomy | Type 3c Diabetes

Netherlands
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Neural-net Artificial Pancreas (NAP) (NAP)

Type1 Diabetes

United States
Air Liquide Santé International

Completed

Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Closed-loop Automatic Insulin Delivery System (SATURN)

Diabetes type1

France
Instituto Valenciano de Infertilidad, IVI VALENCIA

Recruiting

Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters (PROGENDO)

Infertility, Female | ENDOMETRIAL RECEPTIVITY

Spain
University Hospital, Montpellier

Completed

DiaPort Closed-Loop Artificial Pancreas

Type 1 Diabetes Mellitus

France
Rabin Medical Center

Completed

Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home

Type 1 Diabetes

Israel, Germany, Slovenia
Oregon Health and Science University

Completed

Single Hormone Closed Loop Study With PDT Sensor

Type 1 Diabetes Mellitus

United States

Search clinical trials for: Single+hormone+artificial+pancreas

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations